Intelliject changes name
- January 6, 2014
Pharmaceutical company Intelliject Inc. is changing its name to kaléo Inc.
The Richmond-based firm said the name "Intelliject" no longer represented the company’s potential.
Kaléo is a Greek word for “a calling” or “purpose.”
“We are excited that our new name, kaléo, will help to communicate our future as a leader in developing a new generation of personal lifesaving medical products,” Spencer Williamson, president and CEO, said in a statement.
The company has one FDA-approved product, Auvi-Q, which is used to treat life-threatening allergic reactions. Auvi-Q is the size of a credit card and talks users through the injection process with step-by-step directions. The company has other personal lifesaving medical products under development.